Chemoinformaics analysis of GYPSOGENIN-3-O-RHAMNOSYLGLUCURONIDE
| Molecular Weight | 792.96 | nRot | 7 |
| Heavy Atom Molecular Weight | 728.448 | nRig | 41 |
| Exact Molecular Weight | 792.43 | nRing | 7 |
| Solubility: LogS | -3.452 | nHRing | 2 |
| Solubility: LogP | 2.992 | No. of Aliphatic Rings | 7 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 120 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 56 | No. of Aromatic Carbocycles | 0 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 64 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 42 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 0 |
| nHA | 12 | APOL | 124.043 |
| nHD | 7 | BPOL | 73.7533 |
| QED | 0.112 |
| Synth | 5.933 |
| Natural Product Likeliness | 2.748 |
| NR-PPAR-gamma | 0.989 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.001 |
| HIA | 0.945 |
| CACO-2 | -6.007 |
| MDCK | 0.0000397 |
| BBB | 0.224 |
| PPB | 0.779921 |
| VDSS | 0.533 |
| FU | 0.115637 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.392 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.32 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.171 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.084 |
| CYP3a4-inh | 0.053 |
| CYP3a4-sub | 0.012 |
| CL | 0.945 |
| T12 | 0.039 |
| hERG | 0.001 |
| Ames | 0.104 |
| ROA | 0.219 |
| SkinSen | 0.002 |
| Carcinogencity | 0.074 |
| EI | 0.003 |
| Respiratory | 0.825 |
| NR-Aromatase | 0.88 |
| Antiviral | Yes |
| Prediction | 0.856718 |